Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-10-22Clinical Trial Update: Recognition of Abnormal Pediatric Blood Pressures in Primary Care [NA]
This clinical trial update notes that the study on recognizing abnormal blood pressures in children in primary care has completed.
-
FDA approval · 2007-10-19FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2007-10-19FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for carvedilol submitted by Aurobindo Pharma Limited for a generic product.
-
FDA approval · 2007-10-19FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for carvedilol filed by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2007-10-18Clinical Trial Update: Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome
This clinical trial update reports that the study NCT00546013 evaluating abdominal aortic aneurysms and pseudoexfoliation syndrome has been …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-10-16FDA Approved: CARVEDILOL — Supplemental Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's supplemental application for a generic carvedilol product (ANDA 078165). This approval expands the availab…
-
FDA approval · 2007-10-04FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
FDA approved a supplemental application for ZESTORETIC (lisinopril and hydrochlorothiazide) from Almatica Pharma.
-
FDA label_change · 2007-09-26FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2007-09-26FDA Approved: AZOR — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved AZOR, a fixed-dose combination of amlodipine besylate and olmesartan medoxomil, under Cosette Pharmaceuticals' original app…
-
FDA approval · 2007-09-26FDA Approved: AMLODIPINE BESYLATE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for amlodipine besylate, a generic version of the calcium channel blocker used to tre…
-
FDA approval · 2007-09-25FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for benazepril hydrochloride (generic) from Solco Healthcare U.S., LLC.
-
FDA approval · 2007-09-25FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA granted a supplemental approval for the generic combination therapy benazepril hydrochloride and hydrochlorothiazide by Sandoz Inc, for …
-
FDA approval · 2007-09-25FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for the fixed-dose combination bisoprolol fumarate and hydrochlorothiazide, a hypertension treat…
-
CLINICAL_TRIALS trial_result · 2007-09-24Clinical Trial Update: Hypertension in Management of Military Medicine
A clinical trial investigating hypertension in military medicine has been terminated.
-
FDA approval · 2007-09-20FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium from Prasco Laborator…
-
CLINICAL_TRIALS research · 2007-09-20Clinical Trial Update: Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)
A Nagoya University-sponsored clinical trial (NGK Study) is investigating genetic risk factors for metabolic syndrome in company employees, …
-
FDA approval · 2007-09-19FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved hydrochlorothiazide from Aurobindo Pharma Limited under an Original Application (ANDA).
-
FDA approval · 2007-09-11FDA Approved: METOPROLOL TARTRATE — Original Application (Aurobindo Pharma Limited)
FDA approved metoprolol tartrate as an original application generic product for Aurobindo Pharma Limited.
-
FDA approval · 2007-09-06FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for DIOVAN HCT (valsartan and hydrochlorothiazide) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original application for carvedilol (generic) from Glenmark, enabling generic access to carvedilol for the indicated condit…
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Carvedilol on an original application by Dr. Reddy's Laboratories Limited (generic carvedilol).
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Advagen Pharma Ltd)
FDA approved the original application for Carvedilol from Advagen Pharma Ltd, a generic version of carvedilol. The drug is indicated for hyp…
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Sandoz Inc)
The FDA approved a generic version of Carvedilol from Sandoz Inc (ANDA) for multiple cardiovascular indications, including hypertension, hea…
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an original application for carvedilol generic by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2007-09-05FDA Approved: CARVEDILOL — Original Application (Aurobindo Pharma Limited)
FDA approves the original ANDA for carvedilol by Aurobindo Pharma Limited, authorizing a generic version of carvedilol. The approval covers …